Amitriptyline for post-COVID headache: effectiveness, tolerability, and response predictors.

Alicia Gonzalez-Martinez Ángel Luis Guerrero-PeralSusana Arias-RivasLorenzo SilvaÁlvaro SierraAna Beatriz Gago-VeigaDavid Garcia Azorin

Published in: Journal of neurology (2022)

This study provides real-world evidence of the potential benefit of AMT in patients with post-COVID-19 headache, especially in patients with history of TTH and without concomitant nausea.

Keyphrases

coronavirus disease
sars cov
randomized controlled trial
systematic review
open label
respiratory syndrome coronavirus
clinical trial
human health
study protocol